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OBJECTIVES We compared a new two-stage transesophageal atrial pacing stress echocardiography
(TAPSE) protocol with a standard dobutamine stress echocardiography (DSE) protocol.
BACKGROUND Transesophageal atrial pacing stress echocardiography has been proposed as an efficient
alternative to DSE.
METHODS Two-stage TAPSE (85% and 100% of age-predicted maximum heart rate) and DSE (5 to
40 mg/kg/min at 3-min stages with or without atropine) were both performed, in random
sequence, in each patient of a study group of 36 patients. Regional wall-motion analysis,
patient acceptance (1 5 low, 5 5 high), hemodynamics and duration for performing and
interpreting tests were compared.
RESULTS Transesophageal atrial pacing stress echocardiography was successful in 35 of the 36 patients
(feasibility 97%). More TAPSE than DSE studies were called “ischemic” (37% vs. 14%; p 5
0.005). Peak heart rate was higher with TAPSE (144 6 18 vs. 129 6 15 beats/min, p 5
0.0001). Peak cardiac index (4.6 6 2.1 vs. 5.1 6 1.9 liters/min/m2, p 5 0.14), patient
acceptance score (4.2 6 0.7 vs. 3.8 6 1.3, p 5 0.17) and study duration (14.2 6 9.3 vs. 13.3 6
3.3 min, p 5 0.59) were similar. Recovery time (7.1 6 7.6 vs. 16.2 6 15.9 min, p 5 0.0003)
and interpretation time (9.1 6 2.8 vs. 13.5 6 4.4 min, p 5 0.0001) were shorter for TAPSE
than for DSE.
CONCLUSIONS Two-stage TAPSE permits rapid evaluation of cardiac patients. Peak cardiac index and
patient acceptance scores were similar for TAPSE and DSE. Ischemia was detected more
often with TAPSE; this result was attributed to the higher peak heart rate obtained with this
protocol. (J Am Coll Cardiol 2000;36:1659–63) © 2000 by the American College of
Cardiology
Transesophageal atrial pacing stress echocardiography
(TAPSE) has been proposed as an efficient, inexpensive
alternative (1–4) to dobutamine stress echocardiography
(DSE) for the detection of coronary artery disease (CAD).
The heart rate can be rapidly increased, with the result that
myocardial ischemia is produced in regions subtended by
stenosed coronary arteries. By contrast to DSE, termination
of pacing results in nearly instantaneous restoration of the
patient’s intrinsic heart rate.
We reported on 100 patients who underwent DSE and
TAPSE with the use of an 18F flexible pacing catheter (5).
Transesophageal atrial pacing was started 10 beats above the
resting heart rate and was increased 20 beats every 2 min
until the target heart rate of 85% of age-predicted maximum
heart rate or another end point was reached. Feasibility of
TAPSE was 96%. Transesophageal atrial pacing studies
were significantly shorter than those with DSE. There was
excellent concordance between both tests for inducing
specific regional wall-motion abnormalities.
In this study, we evaluated a new rapid two-stage protocol
in which transesophageal atrial pacing was performed at
85% and 100% of age-predicted maximum heart rate, and
we compared the results with those obtained with our
standard dobutamine protocol. Studies were performed with
the use of a new 10F pacing catheter, which was inserted
orally. The target rate of 100% was used for transesophageal
atrial pacing because, in our experience, the ischemic
threshold was 10 beats/min higher with TAPSE than was
observed with DSE (5). In addition, the stroke volume and
cardiac output responses to the two forms of stress testing
were compared by using Doppler methods (6).
METHODS
Study patients. All patients were outpatients more than 40
years of age who were scheduled for clinically indicated
DSE for the evaluation of known or suspected CAD. No
patient had atrial fibrillation or flutter or a permanent
pacemaker or automatic implantable cardiac defibrillator,
and none had moderate or severe valvular heart disease,
gastroesophageal varices, unstable angina pectoris, recent
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myocardial infarction (within two weeks), untreated glau-
coma, uncontrolled systemic hypertension (systolic blood
pressure (BP) .190 mm Hg, diastolic BP $100 mm Hg) or
inadequate transthoracic images. No patient was pregnant.
Thirty-six patients met the study criteria and agreed to
participate. Institutional approval had been obtained.
After fasting for 3 h, each patient underwent both
two-stage TAPSE and DSE in a randomly determined
sequence. The second test was started after a 30-min rest
period, which began with the resolution of any stress-
induced evidence of myocardial ischemia and after the heart
rate had returned to within 10 beats of the baseline heart
rate.
During each protocol, symptoms, heart rate, BP and
adverse effects were recorded. Stroke volume and cardiac
output were measured by the Doppler technique (6) at rest
and at peak stress for both tests. The duration of each study
(start of pacing catheter insertion to termination of pacing
or start of dobutamine infusion to termination of dobut-
amine infusion) was recorded. Also recorded were duration
of recovery period (termination of pacing or dobutamine
infusion to termination of monitoring), time for interpre-
tation of each study and videotape time. At any stage, mild
sedation with midazolam, 1 mg to 2 mg, was given if
necessary to alleviate anxiety, discomfort or gagging. At the
completion of both studies, each patient completed a
questionnaire, scoring the tests for comfort and acceptance
on a scale of 1 (intolerable) to 5 (very satisfactory).
Instrumentation. Transthoracic two-dimensional echo-
cardiography was performed with standard cardiac ultra-
sound equipment. Atrial pacing was performed with bipolar
esophageal cardiac pacing and a recording catheter housed
in a 10F sheath connected to a Model 7A pulse generator
and Model 3 preamplifier (TAPSCOPE-210-S and
TAPSTRESS systems, CardioCommand, Tampa, Florida).
All studies were recorded on 3/4-in. (1.9 cm) videotape.
Images at each level were digitally stored on a Nova
Microsonics system (Allendale, New Jersey). During
TAPSE, the start–delay time interval to digital image
acquisition was increased in accordance with the duration
between the pacing spike and the R wave because the
high-amplitude pacing spike triggered digital image acqui-
sition.
Protocol for two-stage TAPSE. The TAPSE was per-
formed by a cardiologist who had no prior experience with
this technique (A.J.R.), under the direct supervision of a
cardiologist who was experienced with TAPSE (P.A.P.).
The oropharynx was anesthetized with 10% lidocaine spray,
and the pacing catheter was introduced orally by instructing
the patient to swallow while lying in the left lateral decub-
itus position. Catheter position was optimized by maximiz-
ing the size of the esophageal P wave on the electrocardio-
gram (ECG). Pacing was initiated at 85% of the age-
predicted maximum heart rate and at the lowest current that
provided stable atrial capture. Images were then recorded. If
there were no new regional wall-motion abnormalities and
if the patient was tolerating the study, the pacing rate was
increased to 100% of the age-predicted maximum heart rate.
After image acquisition, the pacing catheter was removed.
Blood pressure was recorded at each stage of the protocol.
The test was terminated if there were intolerable symptoms,
significant arrhythmia, ECG evidence of significant isch-
emia (ST depression $2 mm, at 80 ms after the J point),
hypertension (BP .220 mm Hg systolic, $110 mm Hg
diastolic) or hypotension (#90 mm Hg systolic). Atropine
(0.5 mg at 1-min intervals to a maximum dose of 2.0 mg)
was administered if Wenckebach heart block occurred.
Protocol for DSE. The DSE was performed according to
our usual protocol (7) with 3-min stages and a maximum
dose of dobutamine of 40 mg/kg/min. Atropine, starting at
0.5 mg intravenously, repeated every minute to a maximum
total dose of 2.0 mg, was administered at the start of the
40-mg/kg/min stage, as needed, to augment the heart rate.
Standard end points, including achievement of a heart rate
85% of age-predicted maximum, were used.
Image analysis and interpretation. Dobutamine and pac-
ing studies were scored separately by an experienced echo-
cardiographer blinded to the clinical information and the
results of the other study. Interpretation was based on
review of both videotape and digitized images. Regional
wall motion was scored at rest and with stress in each of 16
segments by the standard 1 through 5 scoring system of the
American Society of Echocardiography (8). A normal re-
sponse to stress was characterized by normal or hyperdy-
namic systolic function of all left ventricular segments.
Infarction was characterized by a resting wall-motion ab-
normality that did not change with stress. The development
of new wall-motion abnormalities in one or more segments
or worsening of a resting wall-motion abnormality, includ-
ing deterioration after initial improvement, was considered
as an ischemic response (9). Ejection fraction at baseline and
at peak stress was determined by the method of Quinones
(10) or by visual estimation (11).
Follow-up. Follow-up was obtained by review of medical
records and scripted telephone interviews. Cardiac death,
myocardial infarction, coronary artery bypass surgery and
percutaneous transluminal coronary angioplasty were re-
corded.
Statistical analysis and estimation of agreement of re-
sults. Wilcoxon matched-pairs signed rank and McNemar
tests were used for paired continuous data and paired
proportions, respectively. A p value of ,0.05 was consid-
ered significant. The degree of agreement between results of
Abbreviations and Acronyms
BP 5 blood pressure
CAD 5 coronary artery disease
DSE 5 dobutamine stress echocardiography
ECG 5 electrocardiogram
TAPSE 5 transesophageal atrial pacing stress
echocardiography
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DSE and those of TAPSE was estimated by the kappa
coefficient (1 5 perfect agreement, .0.5 5 good agree-
ment, and .0.8 5 excellent agreement) (12). The degree of
agreement for wall segment scoring was estimated as the
average kappa for all 16 segments, with the standard error
estimated by means of resampling techniques (13).
RESULTS
Transesophageal atrial pacing could not be performed in 1
of the 36 patients enrolled in this study (feasibility 97%).
That patient had a large hiatus hernia. Results in the
remaining 35 patients, who completed both forms of test-
ing, are included here.
The demographics for the patients are described in Table
1. Stress testing was performed for pre-operative evaluation
of noncardiac surgery in 20 patients (57%), for evaluation of
known CAD in 14 (40%) or for evaluation of symptoms of
dyspnea or chest pain in 3 (9%) patients. Thirty of the
patients were unable to exercise, because of orthopedic
limitations in 16 (46%), peripheral vascular disease in 9
(26%), lung disease in 3 (9%) and debility in 2 (6%).
The average pacing current was 18 6 4 milliamps. The
mean peak dose of dobutamine was 33 6 10 mg/kg/min.
Four patients (11%) required midazolam during TAPSE
(dose 1.5 6 0.6 mg) but none during DSE. Atropine was
used more often with TAPSE (63% vs. 37%, p 5 0.05), but
doses were similar (0.95 6 0.67 vs. 0.62 6 0.74 mg, p 5
0.4). Esmolol was used frequently after DSE (49% vs. 0%,
dose 39 6 18 mg) to alleviate symptoms.
Rest and peak systolic and diastolic BPs, rest heart rate,
double product, rest stroke volume and rest ejection fraction
were similar for the two forms of stress. A higher peak heart
rate was achieved with TAPSE compared with DSE (144 6
18 vs. 129 6 14 beats/min, p 5 0.0001). Target heart rate
was achieved in 86% with TAPSE (100% of age-predicted
maximum heart rate) and 89% with DSE (85% of age-
predicted maximum heart rate), p 5 0.74. Stroke volume
decreased from rest to peak stress with TAPSE (82 6 18 vs.
62 6 24 ml, p 5 0.0001); there was no change in stroke
volume from rest to peak stress for DSE (81 6 17 vs. 77 6
22 ml, p 5 0.24). The peak stroke volume was greater for
DSE than for TAPSE (77 6 22 vs. 62 6 24 ml, p 5
0.0001). However, because of the greater heart rate achieved
with TAPSE, the peak cardiac index was similar (4.6 6 2.1
vs. 5.1 6 1.9 liter/min/m2, p 5 0.14). The ejection fraction
increased at peak stress for DSE (62 6 12 vs. 69 6 16%,
p 5 0.0001) but did not change from rest to peak stress with
TAPSE. Ejection fraction was greater at peak stress for
DSE compared with TAPSE (69 6 16 vs. 61 6 16%, p 5
0.0001) (Tables 2 and 3).
Table 1. Demographics in 35 Patients Undergoing Two-Stage
TAPSE and DSE
Category
Number of
Patients (%)
Women 20 (57)
Age (yr 6SD) 71 6 10
Previous MI 4 (11)
Previous CABG/PTCA 3 (9)
Smoking history 21 (60)
Hyperlipidemia 18 (51)
Hypertension 22 (63)
Diabetes mellitus 5 (14)
Family history of CAD 17 (49)
Chest pain 10 (29)
Dyspnea 10 (29)
History of stoke or TIA 7 (20)
Carotid bruit(s) 8 (23)
Normal ECG at baseline 20 (57)
Beta-blocker use 8 (23)
Calcium channel blocker use 8 (23)
Digoxin use 5 (14)
CABG 5 coronary artery bypass grafting; CAD 5 coronary artery disease; ECG 5
electrocardiogram; MI 5 myocardial infarction; PTCA 5 percutaneous transluminal
coronary angioplasty; TIA 5 transient ischemic attack.
Table 2. Comparison of Hemodynamic Variables and Wall Motion Analysis in 35 Patients
Undergoing TAPSE and DSE
Category TAPSE DSE p Value
Systolic BP (mm Hg), rest 146 6 28 143 6 21 0.44
Systolic BP (mm Hg), peak 134 6 30 143 6 37 0.16
Diastolic BP (mm Hg), rest 75 6 12 78 6 13 0.25
Diastolic BP (mm Hg), peak 76 6 12 72 6 15 0.18
Heart rate (beats/min), rest 76 6 13 73 6 12 0.08
Heart rate (beats/min), peak 144 6 18 129 6 15 0.0001
Stroke volume (ml), rest 82 6 18 81 6 17 0.76
Stroke volume (ml), peak 62 6 24 77 6 22 0.0001
Cardiac index (liter/min/m2), rest 3.4 6 1.1 3.2 6 1.1 0.90
Cardiac index (liter/min/m2), peak 4.6 6 2.1 5.1 6 1.9 0.14
Double product 19,285 6 4708 18,503 6 5244 0.35
Ejection fraction, rest 62 6 12 62 6 12 0.93
Ejection fraction, peak 61 6 16 69 6 16 0.0001
WMSI, rest 1.2 6 0.4 1.2 6 0.4 0.40
WMSI, peak 1.5 6 0.6 1.4 6 0.5 0.001
New or worsening RWM 13 (37%) 5 (14%) 0.005
BP 5 blood pressure; double product 5 peak systolic heart rate 3 peak systolic blood pressure; RWM 5 regional wall motion;
WMSI 5 wall-motion score index.
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Wall-motion score index at rest was similar for the two
techniques. At peak stress, the peak wall-motion score index
was greater for TAPSE compared with DSE (1.5 6 0.6 vs.
1.4 6 0.5, p 5 0.001). More ischemic studies were reported
for TAPSE than for DSE (37 vs. 14%, p 5 0.005) (Table
2). Kappa coefficient values for abnormal individual wall
segments between TAPSE and DSE at rest and peak stress
were 0.82 6 0.10 and 0.59 6 0.08, respectively.
Times needed to perform TAPSE and DSE were similar
(14.2 6 9.3 vs. 13.3 6 3.3 min, p 5 0.59). However, the
last 10 TAPSE studies could be performed in less time than
the first 10 TAPSE studies (8.5 6 3.3 vs. 21.5 6 11.8 min,
p 5 0.01) and in less time than the last 10 DSE studies
(8.5 6 3.3 vs. 13.2 6 2.4 min, p 5 0.01). No difference was
seen in a similar comparison between the last and first 10
DSE studies (14.6 6 3.7 vs. 13.2 6 2.4 min, p 5 0.14).
Times for recovery, interpretation and videotape recording
were shorter for TAPSE (Table 4).
Overall, patient acceptance scores were similar for
TAPSE and DSE (4.2 6 0.8 vs. 3.8 6 1.3, p 5 0.17);
however, more patients rated TAPSE 4 or 5 compared with
DSE (89% vs. 64%, p 5 0.02). Side effects occurred less
often with TAPSE than with DSE (34% vs. 83%, p 5
0.0001). No major side effects occurred with TAPSE.
Nonsustained ventricular tachycardia occurred in one pa-
tient with DSE. Minor side effects with DSE included
palpitations 60%, chest pain 20%, nausea 11%, headache
9%, dyspnea 6% and tremor 3%; minor side effects for
TAPSE included gagging 20% and chest pain 6%.
Follow-up was complete in 34 patients (97%); the mean
duration was 9.0 6 2.8 months. Five patients underwent
coronary angiography, and at least one coronary stenosis of
more than 70% of the luminal diameter was found in each
of these patients. Both TAPSE and DSE were positive for
the detection of ischemia in each of these five patients.
Myocardial infarction and cardiac death occurred in one
patient, myocardial infarction and coronary angioplasty in
one patient, coronary artery bypass operation in one patient
and coronary angioplasty in another patient. Both TAPSE
and DSE were positive for the detection of ischemia in each
of these four patients.
DISCUSSION
The results of this study, in which a specially designed 10F
atrial pacing catheter was used, confirm our previous finding
that TAPSE is a safe, feasible and effective method for the
assessment of patients with suspected CAD. This rapid
two-stage technique, using 85% and 100% of age-predicted
maximal heart rate, can be performed and reported in a
shorter period of time than DSE. Transesophageal atrial
pacing was performed by an operator who had no previous
experience with this technique. Experience was rapidly
achieved and resulted in shorter study times, as seen with
the comparison between the first and last 10 TAPSE
studies. Omitting the acquisition of Doppler measurements
would have reduced the time needed to perform the study.
The recovery period was significantly shorter for the
TAPSE protocol, despite the frequent use of esmolol in the
recovery period of the DSE protocol.
Cardiac stroke volume and cardiac index, obtained by
Doppler techniques, have not been previously reported for
transesophageal atrial pacing. Although stroke volume fell
from rest to peak stress, we were able, by obtaining a higher
peak heart rate with TAPSE, to achieve an equivalent
cardiac index with the two techniques. The hemodynamic
changes seen with TAPSE were similar to results obtained
from previous studies using transvenous atrial pacing (14–
19). Peak stroke volumes and ejection fractions were higher
with DSE because of the positive inotropic action of
dobutamine. No differences in systolic or diastolic BPs were
noted.
Agreement for individual wall segments of the two tests
was excellent at rest (kappa 5 0.82) and good at peak stress
(kappa 5 0.59). Myocardial ischemia was detected more
frequently with transesophageal atrial pacing, owing, we
believe, to the higher peak heart rate achieved with TAPSE.
Additional reasons include hyperdynamic response and left
ventricular cavity obliteration seen with DSE, which may
obscure hypokinetic regions, and the lack of gradual warm-
up or ischemic conditioning of the coronary bed with the
rapid-pacing protocol. However, because coronary angiog-
Table 3. Changes in Hemodynamic Variables From Rest to Peak Stress in 35 Patients
Undergoing Two-Stage TAPSE and DSE
Category TAPSE p Value DSE p Value
D Heart rate (beats/min) 68 6 19 0.0001 56 6 13 0.0001
D Systolic BP (mm Hg) 212 6 25 0.001 0 6 36 0.97
D Diastolic BP (mm Hg) 0 6 9 0.80 27 6 14 0.01
D Stroke volume (ml) 219 6 21 0.0001 24 6 16 0.24
D Ejection fraction 21 6 7 0.43 8 6 6 0.0001
D Cardiac index (liter/min/m2) 1.3 6 2.0 0.0007 2.1 6 1.5 0.0001
BP 5 blood pressure; D 5 delta.
Table 4. Comparison of Procedure Duration (Mean 6 SD) in
35 Patients Undergoing Two-Stage TAPSE and DSE
Timing Intervals TAPSE (min) DSE (min) p Value
Study time 14.2 6 9.3 13.3 6 3.3 0.59
Recovery time 7.1 6 7.6 16.2 6 15.9 0.0003
Videotape time 8.2 6 3.2 12.1 6 3.9 0.0002
Review time 9.1 6 2.8 13.5 6 4.4 0.0001
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raphy was not routinely performed, false-positive results
with TAPSE are also a possibility.
The transesophageal atrial pacing catheter used in this
study, TAPSCOPE-210-S, was a new, smaller (10F) cath-
eter. It was highly effective, adequate atrial capture being
obtained in all but one patient. In this patient, a previously
known large hiatal hernia may have interfered with our
obtaining correct catheter position and esophageal wall
contact. Positioning of the pacing catheter was not difficult
and was very well tolerated by the patients. There were
fewer symptoms, and less midazolam was required for
sedation with this smaller atrial pacing catheter compared
with our previous experiences with the larger (18F) catheter
(5). The smaller catheter could also have been placed
nasally; this might have reduced the frequency of gagging.
Study limitations. The number of patients studied was
small. Coronary angiographic data were insufficient for an
estimation of the relative diagnostic accuracy of TAPSE and
DSE. The use of midazolam in four patients during
TAPSE may have affected their preference of forms of
testing.
Conclusions. Transesophageal atrial pacing appears to be
an acceptable technique for the detection of CAD. Potential
roles include its use as an alternative to DSE—especially in
patients who experience intolerable symptoms with dobut-
amine—and in patients who have chronotropic incompe-
tence, including those taking beta-blocking medications, in
whom peak heart rate may be difficult to achieve with
dobutamine. This technique may also be useful in the
emergency room assessment of chest pain syndromes, as
results can be obtained quickly. The rapid return of the
heart rate to pretest level may confer additional safety on
this test. The shorter recovery, interpretation and videotape
times offer potential cost savings for this technique as a
substitute for DSE.
Finally, as no major adverse side effects occurred with
two-stage TAPSE, this rapid technique could be simplified
further to one stage using 100% of the age-predicted
maximum heart rate, which may add other benefits to those
noted above.
Reprint requests and correspondence to: Dr. Patricia A. Pel-
likka, Mayo Clinic, 200 First Street SW, Rochester, Minnesota
55905.
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